Skip To Main Content
Sam Page on Muck Rack

Sam Page

  • Public Relations Representative, Michigan Medicine
New York
As seen in: MSN, Forbes, Sports Illustrated, Men's Health, Medical Xpress, Deadspin, Arizona Daily Star, Comingsoon.it, SportsNet New York (SNY), Simplecast and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sam

Contact Sam, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

IBS treatment response predicted by gut microbiome in new study

|
By Sam Page
| Michigan Medicine
In a new study published in Clinical Gastroenterology and Hepatology, the low FODMAP diet and the antibiotic rifaximin provided similar and significant relief for patients with irritable bowel syndrome with diarrhea (IBS-D). Researchers also observed distinct characteristics of patients’ gut microbiomes that predicted whether they responded to the low FODMAP diet or rifaximin — or did not respond to treatment.
Open in Who Shared View Duplicates (3) Issue with article?

Researchers uncover hundreds of emojis in patient records

|
By Sam Page
| Michigan Medicine
Analysis of 218.1 million notes from 1.6 million patients’ electronic health records revealed growing use of emojis. The results, published in JAMA Network Open, found 372 emojis within 4,162 notes between 2020 and 2025. The incidence of emojis was higher than that found in prior studies of clinical texting systems. “In this exploratory study we set out to determine if emojis, which are often associated with text messaging and social media, have made their way into medical records.
Open in Who Shared View Duplicates (5) Issue with article?

Lactulose and tai chi show promise preventing falls for cirrhosis patients

|
By Sam Page
| Michigan Medicine
Lactulose and tai chi can prevent falls in patients with cirrhosis, according to results from the LiveSMART Trial. Michigan Medicine hepatologists reported the findings as a late breaking abstract at The Liver Meeting 2025 in Washington, D.C. In a two-stage, 24-week controlled trial, patients who received lactulose therapy for 12 weeks, followed by participation in tai-chi for an additional 12 weeks, experienced fewer falls versus a control group.
Open in Who Shared Issue with article?
See all 64 licensed articles (128 Total)